Redwire Opens Space-Based Pharmaceutical Research and Manufacturing Facility in Southern Indiana
核心洞察
Redwire (搜索) officially opened a 30,000-square-foot space research and manufacturing facility in Georgetown, Indiana, dedicated to pharmaceutical drug research and technology development for space.
The facility enables real-time communication with astronauts on the International Space Station through a Payload Operations Control Center, optimizing microgravity experiments.
Research includes using a bio-printer on the ISS to create blood vessels, with the long-term goal of printing whole organs in space using patient stem cells for transplantation.
Redwire (搜索), a leader in space infrastructure and innovation, officially opened its new 30,000-square-foot research and manufacturing facility in Georgetown, Indiana, on Monday, marking a significant expansion of space-based pharmaceutical research capabilities in the American Midwest. Indiana Governor Mike Braun joined Redwire executives, former NASA astronauts, and business leaders to commemorate the occasion.
The facility, which took more than two years to construct, houses multiple laboratories dedicated to pharmaceutical drug research, life sciences, crop production studies, and technology development — all designed to leverage the unique conditions of microgravity.
A Direct Line to the International Space Station
Central to the new facility is a Payload Operations Control Center, which allows researchers in Georgetown to communicate directly with astronauts conducting experiments aboard the International Space Station in real time.
"We are able to talk directly with the astronauts who are conducting our experiments, and so it's super exciting because we get to help them optimize their time," said John Vellinger, Executive Vice President at Redwire (搜索). "It helps the crew optimize our experiments more efficiently, but it's so cool because you're talking live to space from right here in Georgetown, Indiana."
The company sends products from Indiana to Florida approximately four to five times per year, loading them onto both manned and unmanned missions to the ISS.
Bioprinting Organs in Microgravity
Among the most ambitious projects underway is Redwire (搜索)'s bio-printer, currently operating on the International Space Station, which is being used to create blood vessels. The ultimate goal is to bioprint entire organs in space using a patient's own stem cells, which could then be transplanted back on Earth.
Rich Boling, Senior Vice President at Redwire (搜索), explained the scientific rationale: "If you tried to print on earth, without adding any kind of thickeners or any kind of chemistry like that, everything would settle out, the heavy cells would be not where you wanted them. In space, we print with only bio-inks because it's a bio printer, everything stays exactly where you put it — nothing settles out."
Boling further detailed that the company has determined through experimentation that a minimum of two weeks of culturing and conditioning in space is required before the tissue can withstand gravity and be returned to Earth.
Pharmaceutical Partnerships and Drug Development
Redwire (搜索) is actively collaborating with some of the largest medication companies in the United States, including Eli Lilly, to research drug development in microgravity. The company's studies indicate that space conditions can improve drug solubility — a critical factor in medication absorption.
"You want to take a pill and have it just pass right through you, right? You want it to be absorbed into the body, so solubility — it is super important to that," Vellinger noted.
Additionally, Redwire (搜索) is exploring how space-based crystallization can revive drug candidates that previously failed to reach market. "A lot of times the pharmaceutical industry has drugs that don't ever make it to market that could be utilized for a lot of these radical diseases, and so by coming up with a new crystal structure in space we can help them develop new drugs," Vellinger said. The company's pharmaceutical research also aims to impact diabetes (搜索) and cancer (搜索) treatment.
Supporting Astronaut Health and Deep Space Missions
Beyond pharmaceutical applications, the facility is developing technology to help astronauts maintain muscle mass and bone density during extended spaceflight and to support the future of commercial space stations. Researchers are also investigating methods to grow food and supply energy for long-term missions. A new 3D metal printing system is under development for deep space crews, addressing the practical challenge of manufacturing replacement parts during missions that can take eight to nine months each way.
Indiana's Space Legacy Continues
The opening places Indiana's role in space exploration back in the spotlight. The state has deep aerospace roots — Gus Grissom from Mitchell, Indiana, was one of NASA's original seven astronauts, and Neil Armstrong graduated from Purdue University.
Retired astronauts Charles Walker and Ken Bowersox, both Hoosiers, attended the grand opening. Walker, who flew on three space shuttle missions as the first astronaut not employed by NASA, reflected on the significance: "I'm just proud to have had the opportunity to be a pioneer, so to speak, in learning how to use microgravity to benefit all of us with better medicines, better biological materials, research like that out in space."
Bowersox, who flew on four shuttle missions, added: "Southern Indiana had a foothold at the beginning of the space age and now here with Redwire (搜索) it's back here in a bigger and better way."
Redwire (搜索)'s next launch to the International Space Station is expected in September.